Therefore, this study assessed the frequency of expanded circulating Th1-, Th17- and Th1/17-like CD3+CD4+ and CD3+CD8+ cells from OGJ cancer patients who underwent surgical tumour resection to determine how major oncologic surgery affects systemic Th1, Treg and Th17 immunity (Figure 1A). The gene discussed is CD8A; the disease is neoplasm.